Recent research shows that nuclear localization of IGF1R leads to higher cell proliferation rates and earlier tumor development in pediatric gliomas, while cells become sensitive to OSI906 treatment, providing a new therapeutic direction for patients with gliomas with nuclear IGF1R localization [111]. The gene discussed is IGF1R; the disease is central nervous system cancer.